In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Introduction: Breast cancer is among the most prevalent mortal cancers in women worldwide. In the present study, an optimum formulation of letrozole, letrozole-loaded niosome, and empty niosome was developed, and the anticancer effect was assessed in in vitro MCF-7, MCF10A and MDA-MB-231 breast cancer cell lines. Materials and Methods: Various niosomal formulations of letrozole were fabricated through thin-film hydration method and characterized in terms of size, polydispersity index (PDI), morphology, entrapment efficiency (EE%), release kinetics, and stability. Optimized niosomal formulation of letrozole was achieved by response surface methodology (RSM). Antiproliferative activity and the mechanism were assessed by MTT assay, quantitative real-time PCR, and flow cytometry. Furthermore, cellular uptake of optimum formulation was evaluated by confocal electron microscopy. Results: The formulated letrozole had a spherical shape and showed a slow-release profile of the drug after 72 h. The size, PDI, and eEE% of nanoparticles showed higher stability at 4°C compared with 25°C. The drug release from niosomes was in accordance with Korsmeyer–Peppa’s kinetic model. Confocal microscopy revealed the localization of drug-loaded niosomes in the cancer cells. MTT assay revealed that all samples exhibited dose-dependent cytotoxicity against breast cancer cells. The IC 50 of mixed formulation of letrozole with letrozole-loaded niosome (L + L 3 ) is the lowest value among all prepared formulations. L+L 3 influenced the gene expression in the tested breast cancer cell lines by down-regulating the expression of Bcl 2 gene while up-regulating the expression of p53 and Bax genes. The flow cytometry results revealed that L + L 3 enhanced the apoptosis rate in both MCF-7 and MDA-MB-231 cell lines compared with the letrozole (L), letrozole-loaded niosome (L 3 ), and control sample. Conclusion: Results indicated that niosomes could be a promising drug carrier for the delivery of letrozole to breast cancer cells. Graphical Abstract: Keywords: breast cancer, niosome, letrozole, drug delivery system, anticancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Haseli, S., Pourmadadi, M., Samadi, A., Yazdian, F. A., Abdouss, M., Rashedi, H., & Nigjeh, M. N. (2022) · Biotechnology Progress · doi:10.1002/btpr.3280 · Cited by 83 · cited 1×
“Development of targeted drug delivery systems (DDSs) has received extensive attention.(12,13,14,15) The combination of medicine and nanotechnology has modified multifunctional nanocarriers that can be loaded with different drugs.”
BackgroundRetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 1×
“Introduction Over the past decade a surge of breast cancer incidence was observed among the female population.(1,2) Most breast cancers are hormone-dependent and estrogen is a mediator hormone in progression and metastasis of tumor cells.”
BackgroundRe-epithelialization and immune cell behaviour in an ex vivo human skin model
Rakita, A., Nikolić, N., Mildner, M., Matiasek, J., & Elbe-Bürger, A. (2020) · Scientific Reports · doi:10.1038/s41598-019-56847-4 · Cited by 8,228
Mechanisms of solute release from porous hydrophilic polymers
Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P., & Peppas, N. A. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90064-9 · Cited by 5,258 · cited 1×
“85) indicate that drug release is based on Fickian diffusion release.(65,66) More stability of the niosomes stored at 4 ± 2°C is possibly due to less mobility of bilayer at this temperature.”
BackgroundLive or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Kinetic modeling on drug release from controlled drug delivery systems.
Dash, S., Murthy, P. N., Nath, L., & Chowdhury, P. (2010) · PubMed · Cited by 2,733
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561 · cited 1×
“Polymeric nanoparticles penetrate into cancer cells, diffuse in the cytoplasm, and escape from endosomal degradation.(56,84,85) Another study revealed that nanoparticles of mesoporous silica could enter the cells and remain for a long time which is enough to allow the release of drug from formulation.”
BackgroundNonionic surfactant vesicular systems for effective drug delivery—an overview
Kumar, G. P., & Rajeshwarrao, P. (2011) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2011.09.002 · Cited by 644
Dombernowsky, P., Smith, I., Falkson, G., Leonard, R., Panasci, L., Bellmunt, J., Bezwoda, W., Gardin, G., Gudgeon, A., Morgan, M., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.453 · Cited by 638 · cited 1×
“5 mg/day dosage of letrozole was associated with poorer response rates in this study.(76) In another study which developed and evaluated the effect of letrozole-loaded hyaluronic acid/chitosan-coated poly(d,l-lactide-co-glycolide) nanoparticles on 24 female albino mice (20–25 g) it was found that 300 mg/kg of the letr…”
ResultVaseva, A. V., & Moll, U. M. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.10.005 · Cited by 618
Research works printed but not linked: 17
- Bray, 2018, CA, 68, 394
- Sarhadi, 2020, Trans Appl Sci, 6, 309
- Cohen, 2002, Clin Cancer Res, 8, 665
- 2020, Niosomal Delivery of Simvastatin to MDA-MB-231 Cancer Cells
- Azizi, 2015, J Chem Pharm Res, 7, 423
- Nowroozi, 2018, Iran J Pharm Sci, 17, 1
- 2020, Optimization and Characterization of Tannic Acid Loaded Niosomes for Enhanced Antibacterial and Anti-Biofilm Activities
- Dash, 2010, Acta Pol Pharm, 67, 217
- 2015, Strategies to Modify the Drug Release from Pharmaceutical Systems
- Sadeghi, 2020, Pharm Chem J, 53, 1, 10.1007/s11094-020-02100-6 · DOI
- Lawrence, 1996, STP Pharma Sci, 6, 49
- Seras-Cansell, 1996, STP Pharma Sci, 6, 12
- Pardakhty, 2011, DARU J Pharm Sci, 19, 404
- Trunet, 1993, J Clin Endocrinol Metab, 77, 319, 10.1210/jcem.77.2.8345034 · doi:10.1210/jcem.77.2.8345034 · Paper page
- Radwan, 2021, J Pharm Innov, 17, 1
- Khorani, 2022, J. Alzheimer’s Dis, 1
- Amiri, 2016, Asian Pac J Cancer Prev, 17, 3835
Cited by
Dastneshan, A., Rahiminezhad, S., Mezajin, M. N., Jevinani, H. N., Akbarzadeh, I., Abdihaji, M., Qahremani, R., Jahanbakhshi, M., Lalami, Z. A., Heydari, H., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.140544 · Cited by 120
Self-citationBazzazan, S., Moeinabadi‐Bidgoli, K., Lalami, Z. A., Bazzazan, S., Mehrarya, M., Yeganeh, F. E., Hejabi, F., Akbarzadeh, I., Noorbazargan, H., Jahanbakhshi, M., et al. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104009 · Cited by 74
Self-citationCurcumin-Incorporated Biomaterials: In silico and in vitro evaluation of biological potentials
Torbat, N. A., Akbarzadeh, I., Rezaei, N., Moghaddam, Z. S., Bazzazan, S., & Mostafavi, E. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215233 · Cited by 35
Self-citationBadivi, S., Kazemi, S., Eskandarisani, M., Moghaddam, N. A., Mesbahian, G., Karimifard, S., & Afzali, E. (2024) · Scientific Reports · doi:10.1038/s41598-024-68156-6 · Cited by 29
Khaledizadeh, E., Tafvizi, F., & Jafari, P. (2023) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2023.127357 · Cited by 29
Metadata
- Authors
- Ahmadi, S., Seraj, M., Chiani, M., Hosseini, S., Bazzazan, S., Akbarzadeh, I., Saffar, S., & Mostafavi, E.
- Affiliations
- Pasteur Institute of Iran (IR)
- Shahid Beheshti University (IR)
- Stanford Medicine (US)
- Corresponding author
- Mostafavi, Ebrahim
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2022-12
- Volume
- Volume 17
- Pages
- 6233-6255
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- PMC
- PMC9753765
- OpenAlex
- W4311260165
- Cited by
- 44
- References
- 85
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 10 · 2023: 10 · 2022: 2
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Nanomedicine (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- Pasteur Institute of Iran
- National Institute of Biomedical Imaging and Bioengineering (T32EB009035)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
- Keywords
- letrozole, niosomes, breast cancer, controlled drug release, anticancer drug delivery, apoptosis, Bcl-2, p53, Bax, MCF-7 cells, MDA-MB-231 cells, MCF10A cells, cytotoxicity, Korsmeyer-Peppas kinetics, encapsulation efficiency, cellular uptake
- MeSH terms
- Letrozole, Breast Neoplasms, Delayed-Action Preparations, Female, Humans, Liposomes, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment. https://app.cochat.ai/papers/10.2147/ijn.s384085
- The paper
- Ahmadi, S., Seraj, M., Chiani, M., Hosseini, S., Bazzazan, S., Akbarzadeh, I., Saffar, S., & Mostafavi, E. (2022). In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s384085
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.